Overview

Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy

Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether rosuvastatin decreases measures of inflammation in depressive patients.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Akershus
Collaborators:
AstraZeneca
Oslo University Hospital
Treatments:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Rosuvastatin Calcium